SOURCE: Equity News Circuit

Equity News Circuit

May 03, 2013 08:00 ET

Squawk Box Stocks Reports on: Facebook Inc. (NASDAQ: FB), Yelp, Inc. (NYSE: YELP), LinkedIn Corporation (NYSE: LNKD), AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO)

Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit

NEW YORK, NY--(Marketwired - May 3, 2013) - Facebook Inc. (NASDAQ: FB), Yelp, Inc. (NYSE: YELP), LinkedIn Corporation (NYSE: LNKD), AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO).

Facebook, Inc. (FB) saw shares advancing 5.61% or $1.54 per share to close at $28.97 on volume of 102,759,853 shares traded during Thursday's trading session. The social networking company announced its latest quarterly results, reporting revenues just under $1.5 billion. The company showed a profit of nearly $220 million for the quarter but this fell short of analysts' expectations. CEO Mark Zuckerberg blamed the missed target on higher costs. Company spending is up 60 percent this quarter over the previous one due to hiring and new developments, but the investments seem to be paying off with Facebook's mobile strategy. It now has more than 750 million active mobile users and mobile advertising accounts for 30 percent of Facebook's ad sales. Will shares of Facebook continue to rise following the company's latest earnings announcement as investors look toward continued growth ahead? Find out what to expect next in our exclusive research report at:

Yelp, Inc. (YELP) saw shares rising 27.35% to close yesterday's trading session at $32.22 on volume of 10,129,818 shares traded. The company had its biggest gain in more than a year after first-quarter revenue topped analysts' estimates, helped by an expansion into new markets and a jump in local advertising on its consumer-review website. Yelp also issued a forecast for second-quarter sales that may exceed analysts' projections. Find out our thoughts & what to expect from Yelp next following its latest earnings report in our exclusive research report at:

LinkedIn Corporation. (LNKD) saw shares advancing 3.52% or $6.85 per share to close yesterday at $201.67 on volume of 6,392,231 shares traded leading up to the companies earnings report. After hours the company saw shares off as much as 12% to under $180.00 as the company reported that revenue had missed the high bar that Wall Street had set for the fast-growing social media company. The online social network for professionals said current-quarter revenue would range from $342 million to $347 million, below the $359.3 million expected on average by analysts, according to Thomson Reuters. Although LinkedIn hiked its full-year revenue forecast by $20 million on Thursday, the high end of the forecast range was below the average analyst estimate of $1.49 billion. Find out our thoughts following LindedIn's earnings report in our exclusive research report at:

AVEO Pharmaceuticals, Inc. (AVEO) saw shares declining 49.62% or $2.61 per share to close yesterday at $2.65 on volume of 15,226,922 shares traded. The therapeutics company failed to win the backing of U.S. regulatory advisers for its lead product candidate, a kidney cancer drug, after the panelists questioned whether it was as effective as existing treatments. Members of the Food and Drug Administration advisory panel expressed concerns that a final-stage trial showed Aveo's tivozanib may reduce survival compared with Bayer AG and Onyx Pharmaceuticals Nexavar. Aveo was criticized for relying on a single-final phase clinical trial and the panel said the company should conduct another study to better assess the benefits. The FDA is scheduled to decide by July 28 whether to approve tivozanib, a drug that may generate sales of $205 million in 2016 for Cambridge, Massachusetts-based Aveo, according to the average of three analysts' estimates compiled by Bloomberg. Will shares of Aveo recover following this negative advisory panel decision leading up to the FDA's final ruling? Find out our thoughts in our exclusive research report at:

Squawk Box Stocks offers its daily stock alerts and market content newsletter to investors looking for timely information available! Our experienced team provides you only the best stock alerts & research reports delivered to your email inbox for FREE. Our track record of providing winning alerts has won us the trust of thousands of investors worldwide. With our dedicated research team & investor database continuing to grow we have become a leading destination for the most profitable opportunities that are available in today's stock market. To receive our FREE, comprehensive newsletter, visit

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein.

A third party, Winning Media LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information

  • Contact Information:
    Winning Media LLC
    Email Contact